Delivery Order SPE2DB20D1050-SPE2DB25FH75T
Award Date 7/7/25
Potential Completion Date 7/8/25
Potential Value $5.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of DUPIXENT 300 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with a ceiling value of $31,077.04 and a performance period ending on July 10, 2025. The contract is a firm-fixed price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corporation holds...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DUPIXENT 300 MG/2 ML SYRINGE 2ML, a medical product, with a ceiling value of $23,527.87 and a performance period through June 27, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DUPIXENT 300 MG/2 ML SYRINGE 2ML, with a ceiling value of $3,418.92 and a period of performance through May 22, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DUPIXENT 300 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with a ceiling value of $17,116.46 and a performance period through May 9, 2024. The contract is a firm fixed-price delivery order, and there was no set-aside designation, indicating open competition. AmerisourceBergen holds...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of a medication called DUPIXENT 300 MG/2 ML SYRINGE 2ML, with a ceiling value of $17,544.73 and a performance period extending through June 23, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of DUPIXENT 300 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with a ceiling value of $3,418.92 and a completion date of July 8, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DUPIXENT 300 MG/2 ML SYRINGE 2ML, a specialty pharmaceutical product, with a ceiling value of $4,131.19 and a period of performance through March 12, 2025. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DUPIXENT 300 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with a ceiling value of $4,877.82 and a period of performance through June 16, 2025. The contract is a firm fixed-price delivery order and is not set aside for any particular business type. Amerisourcebergen Drug...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of DUPIXENT 300 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with a ceiling value of $7,443.09 and a completion date of June 4, 2025. The contract is a firm fixed-price type, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and has a significant...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DUPIXENT 300 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with a ceiling value of $9,477.12. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop...